Dataset Information

Towards Intelligent Drug Design System: Application of Artificial Dipeptide Receptor Library in QSAR-Oriented Studies.

ABSTRACT: The pharmacophore properties of a new series of potential purinoreceptor (P2X) inhibitors determined using a coupled neural network and the partial least squares method with iterative variable elimination (IVE-PLS) are presented in a ligand-based comparative study of the molecular surface by comparative molecular surface analysis (CoMSA). Moreover, we focused on the interpretation of noticeable variations in the potential selectiveness of interactions of individual inhibitor-receptors due to their physicochemical properties; therefore, the library of artificial dipeptide receptors (ADP) was designed and examined. The resulting library response to individual inhibitors was arranged in the array, preprocessed and transformed by the principal component analysis (PCA) and PLS procedures. A dominant absolute contribution to PC1 of the Glu attached to heptanoic gating acid and Phe bonded to the linker m-phenylenediamine/triazine scaffold was revealed by the PCA. The IVE-PLS procedure indicated the receptor systems with predominant Pro bonded to the linker and Glu, Gln, Cys and Val directly attached to the gating acid. The proposed comprehensive ligand-based and simplified structure-based methodology allows the in-depth study of the performance of peptide receptors against the tested set of compounds.

SUBMITTER: Bak A

PROVIDER: S-EPMC6222794 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:In order to carry out a comprehensive design description of the specific architectural model of AI, the auxiliary model of AI and architectural spatial intelligence is deeply integrated, and flexible design is carried out according to the actual situation. AI assists in the generation of architectural intention and architectural form, mainly supporting academic and working theoretical models, promoting technological innovation, and thus improving the design efficiency of the architectural design industry. AI-aided architectural design enables every designer to achieve design freedom. At the same time, with the help of AI, architectural design can complete the corresponding work faster and more efficiently. With the help of AI technology, through the adjustment and optimization of keywords, AI automatically generates a batch of architectural space design schemes. Against this background, the auxiliary model of architectural space design is established through the literature research of the AI model, the architectural space intelligent auxiliary model, and the semantic network and the internal structure analysis of architectural space. Secondly, to ensure compliance with the three-dimensional characteristics of the architectural space from the data source, based on the analysis of the overall function and structure of space design, the intelligent design of the architectural space auxiliary by Deep Learning is carried out. Finally, it takes the 3D model selected in the UrbanScene3D data set as the research object, and the auxiliary performance of AI's architectural space intelligent model is tested. The research results show that with the increasing number of network nodes, the model fitting degree on the test data set and training data set is decreasing. The fitting curve of the comprehensive model shows that the intelligent design scheme of architectural space based on AI is superior to the traditional architectural design scheme. As the number of nodes in the network connection layer increases, the intelligent score of space temperature and humidity will continue to rise. The model can achieve the optimal intelligent auxiliary effect of architectural space. The research has practical application value for promoting the intelligent and digital transformation of architectural space design.

Project description:BackgroundCharacterization of anti-malarial drug concentration profiles is necessary to optimize dosing, and thereby optimize cure rates and reduce both toxicity and the emergence of resistance. Population pharmacokinetic studies determine the drug concentration time profiles in the target patient populations, including children who have limited sampling options. Currently, population pharmacokinetic studies of anti-malarial drugs are designed based on logistical, financial and ethical constraints, and prior knowledge of the drug concentration time profile. Although these factors are important, the proposed design may be unable to determine the desired pharmacokinetic profile because there was no formal consideration of the complex statistical models used to analyse the drug concentration data.MethodsOptimal design methods incorporate prior knowledge of the pharmacokinetic profile of the drug, the statistical methods used to analyse data from population pharmacokinetic studies, and also the practical constraints of sampling the patient population. The methods determine the statistical efficiency of the design by evaluating the information of the candidate study design prior to the pharmacokinetic study being conducted.ResultsIn a hypothetical population pharmacokinetic study of intravenous artesunate, where the number of patients and blood samples to be assayed was constrained to be 50 and 200 respectively, an evaluation of varying elementary designs using optimal design methods found that the designs with more patients and less samples per patient improved the precision of the pharmacokinetic parameters and inter-patient variability, and the overall statistical efficiency by at least 50%.ConclusionOptimal design methods ensure that the proposed study designs for population pharmacokinetic studies are robust and efficient. It is unethical to continue conducting population pharmacokinetic studies when the sampling schedule may be insufficient to estimate precisely the pharmacokinetic profile.

Dataset Information

Towards Intelligent Drug Design System: Application of Artificial Dipeptide Receptor Library in QSAR-Oriented Studies.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets